Ontology highlight
ABSTRACT: Introduction
Generalized pustular psoriasis (GPP) is a chronic, rare, and potentially life-threatening skin condition characterized by flares comprising widespread sterile pustules and systemic inflammation. Both the rarity and heterogeneity of the disease have made GPP classification and standardization of clinical criteria challenging. Before the approval of spesolimab (IL-36R antibody) in 2022, there were no approved treatments in the USA or Europe for GPP flares. Treatment for GPP has amounted to off-label use of medicines approved to treat plaque psoriasis. Our aim was to describe the sociodemographics, clinical characteristics, and treatment patterns of patients with GPP in Spain.Methods
Non-interventional, descriptive, multi-center, retrospective chart review of pati
SUBMITTER: Puig L
PROVIDER: S-EPMC11651324 | biostudies-literature | 2024
REPOSITORIES: biostudies-literature